Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615095 · ClinicalTrials.gov registry record
Differential Risks for Melanoma: p16 and DNA Repair
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 323
- Enrollment target
NCT00615095: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00615095 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 323 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00615095 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 323 participants
- Enrollment target
Study Summary
The goal of this study is to find out if some people are more likely to get melanoma, a form of skin cancer, than others. People respond to the environment in different ways. Some may be born with genes that make them more likely to get this type of skin cancer. Genes are made up of DNA. DNA damage is one of the first steps in developing cancer. Each person has many ways to repair normal damage to their genes. Some people may have a lower level of this repair and that may make them more likely to get cancer. Some genes are important for DNA repair. The genes we want to test are thought to affect the rate at which DNA can be repaired. We also want to find out if sun habits are related to these levels of DNA repair or genetic mutations.
Interventions
- OTHER self-administered questionnaire and blood draw
- OTHER health questionnaire, blood draw and skin exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 1997-02 |
| Est. Completion | 2011-04 |
What the finished NCT00615095 record still lists
NCT00615095 is an observational study that tracks outcomes without assigning an intervention. The registered 323 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which self-administered questionnaire and blood draw is the first listed.
NCT00615095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00615095 about?
NCT00615095 is a clinical study titled "Differential Risks for Melanoma: p16 and DNA Repair". The goal of this study is to find out if some people are more likely to get melanoma, a form of skin cancer, than others. People respond to the environment in different ways. Some may be born with genes that make them more likely to get this type of skin cancer. Genes are made up of DNA. DNA damage ...
What is the current status of trial NCT00615095?
This trial is currently completed. The enrollment target is 323 participants. The study started on 1997-02. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00615095?
The interventions under investigation include: self-administered questionnaire and blood draw (OTHER), health questionnaire, blood draw and skin exam (OTHER).
Who is sponsoring clinical trial NCT00615095?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia